General Information of Drug (ID: DMHT5XV)

Drug Name
REC-02 Drug Info
Indication
Disease Entry ICD 11 Status REF
Congestive heart failure BD10 Phase 1 [1]
Cross-matching ID
TTD Drug ID
DMHT5XV

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Dociparstat sodium DMQLSMB Acute myeloid leukaemia 2A60 Phase 3 [2]
MyoCell SDF-1 DMS9GE1 Heart failure BD10-BD13 Phase 3 [3]
SDF-1 DM80HOV Heart failure BD10-BD13 Phase 2 [4]
NOX-A12 DMMKN4Q Macular degeneration 9B78.3 Phase 1 [5]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Stromal cell-derived factor 1 (CXCL12) TT4UGTF SDF1_HUMAN Modulator [1]

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Clinical pipeline report, company report or official report of Chimerix.
3 Stromal cell-derived factor-1 (SDF-1): homing factor for engineered regenerative medicine. Expert Opin Biol Ther. 2011 Feb;11(2):189-97.
4 SDF-1 in myocardial repair. Gene Ther. 2012 Jun;19(6):583-7.
5 SDF-1/CXCR4/CXCR7 is pivotal for vascular smooth muscle cell proliferation and chronic allograft vasculopathy. Transpl Int. 2015 Dec;28(12):1426-35.